Story perspectives

Breakthroughs in Cancer Research and Genetic Treatments Revealed

9/20/2025

Summary

Story summary

Researchers at the Institute of Cancer Research (ICR) found extrachromosomal DNA (ecDNA) in early glioblastoma development, suggesting it may drive tumor aggressiveness and treatment resistance.
This discovery indicates potential for early detection and intervention.
A Phase 1/2 clinical trial for SAR446268, a gene therapy for myotonic dystrophy type 1, is assessing safety and efficacy.
The trial uses a modified adeno-associated virus to deliver microRNA that reduces harmful DMPK mRNA in muscle cells.
In Maharashtra, India, a couple had a healthy baby free from spinal muscular atrophy through a structured IVF treatment plan with genetic testing.

1 of 1

Story summary

Researchers at the Institute of Cancer Research (ICR) found extrachromosomal DNA (ecDNA) in early glioblastoma development, suggesting it may drive tumor aggressiveness and treatment resistance.
This discovery indicates potential for early detection and intervention.
A Phase 1/2 clinical trial for SAR446268, a gene therapy for myotonic dystrophy type 1, is assessing safety and efficacy.
The trial uses a modified adeno-associated virus to deliver microRNA that reduces harmful DMPK mRNA in muscle cells.
In Maharashtra, India, a couple had a healthy baby free from spinal muscular atrophy through a structured IVF treatment plan with genetic testing.